RN7SL503P

Across TCGA pan-cancer cohorts, RN7SL503P RNA is linked to patient survival in 16 of 34 cancer types, making it the most broadly survival-associated RN7SL503P data layer.

The strongest signal is observed in breast invasive carcinoma (BRCA), where higher RN7SL503P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RN7SL503P expression acts as an unfavorable survival marker, although some lineages such as ESCA and SARC show a favorable association.

BRCA, MESO, and ACC are the cancer types where RN7SL503P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BRCA	OS	Tertile	All	0.315	0.606	.002	30	view →
MESO	OS	Tertile	II,III,IV	0.137	0.587	.004	27	view →
ACC	OS	Tertile	III,IV	0.251	0.789	<.001	27	view →
KICH	OS	Tertile	III,IV	0.178	0.847	<.001	18	view →
LUAD	DFS	Tertile	IV	0.484	0.936	.001	18	view →
UCS	DFS	Tertile	All	0.186	0.535	.031	18	view →
LIHC	DFS	Tertile	III,IV	0.128	0.369	.019	18	view →
ESCA	OS	Quartile	III,IV	0.590	0.320	.007	15	view →
KIRC	DFS	Tertile	III,IV	0.219	0.507	.013	12	view →
LGG	OS	Tertile	All	0.263	0.539	.031	9	view →
STAD	DFS	Quartile	IV	0.087	0.412	.003	6	view →
CESC	OS	Tertile	III,IV	0.538	0.773	.048	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 16 lineages.

RN7SL503P–BRCA (OS)

Open the BRCA breakdown →